SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-19-039677
Filing Date
2019-02-14
Accepted
2019-02-14 10:29:02
Documents
1
Group Members
CHARLES I. CLOUGH, JR.CLOUGH CAPITAL PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d672808dsc13g.htm SC 13G 82679
  Complete submission text file 0001193125-19-039677.txt   84482
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Correvio Pharma Corp. (Subject) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60635 | Film No.: 19602185
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE POST OFFICE SQUARE 40TH FLOOR BOSTON MA 02109
Business Address ONE POST OFFICE SQUARE 40TH FLOOR BOSTON MA 02109 6172043400
CLOUGH CAPITAL PARTNERS L P (Filed by) CIK: 0001276144 (see all company filings)

IRS No.: 043486480 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G